ArticleCurrent microbiology2026
Two Novel Trichoderma Species and their Antagonistic Activity against Sclerotia-producing Plant Pathogens.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trichoderma species are among the most employed fungal biocontrol agents in global agriculture. One mechanism of activity of these fungi is mycoparasitism, which is responsible for degrading the cell wall of other fungi through the production of enzymes such as chitinases and cellulases. This mechanism is capable of targeting resistant structures like sclerotia and chlamydospores produced by pathogens such as Sclerotinia sclerotiorum and Stromatinia cepivora. Several Trichoderma species have been reported as antagonists of these pathogens, but most described species were not explored for their antagonism against sclerotia-producing pathogens. The objective of this study was to characterize new species of the Trichoderma genus and evaluate their antagonistic potential against pathogens that produce sclerotia. The taxonomical novelties reported in this study are the description of two novel species, T. variabile and T. littericola from the Restinga ecosystem and T. nordicum is reported from Brazil, showing that this species has a broader distribution than previously thought. In addition to that, T. nigricans was shown to be an invalid species that should be considered a synonym of T. nordicum according to the rule of priority in taxonomical descriptions. These strains showed antagonistic potential against S. sclerotiorum and S. cepivora in vitro, especially T. nordicum and T. littericola, which were superior to T. harzianum from a commercial product. This study contributed to extend our knowledge on the diversity of Trichoderma species from the Restinga ecosystem and points out to their potential use in the biological control of plant pathogens that produce sclerotia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.